Evidence map›Paper›PMID 32668109›Full record

ArticleThe New England journal of medicine2020

Hydroxychloroquine as Postexposure Prophylaxis for Covid-19. Reply.

Elizabeth C Okafor, Katelyn A Pastick, Radha Rajasingham

Registry-linked trialAbstract readLetterComment
PubMed Publisher
In one paragraph

Article in The New England journal of medicine, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT04308668 (Post-exposure Prophylaxis or Preemptive Therapy for SARS-Coronavirus-2), which is not on this map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT04308668 phase3completednot on this map

Post-exposure Prophylaxis or Preemptive Therapy for SARS-Coronavirus-2: A Pragmatic Randomized Clinical Trial

TypeinterventionalSponsorUniversity of MinnesotaRan2020 to 2020Enrolled1,312ConditionsCorona Virus Infection, Acute Respiratory Distress Syndrome, SARS-CoV Infection, CoronavirusArmsHydroxychloroquine, Placebo
3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

3 authors.

Elizabeth C OkaforUniversity of Minnesota, Minneapolis, MN radha@umn.edu.
Katelyn A PastickUniversity of Minnesota, Minneapolis, MN radha@umn.edu.
Radha RajasinghamUniversity of Minnesota, Minneapolis, MN radha@umn.edu.

Funding

Evaluation of CRAG screening with enhanced antifungal therapy for asymptomatic CRAG-positive personsK23AI138851 · NIAID · UNIVERSITY OF MINNESOTA · PI RAJASINGHAM, RADHA · 2018 to 2022
$954k
NIAID NIH HHS K23 AI138851
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

BetacoronavirusPandemicsCoronavirus InfectionsCOVID-19COVID-19 Drug TreatmentHumansHydroxychloroquinePneumonia, ViralSARS-CoV-2Hydroxychloroquine

Identifiers

PMID32668109

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.